Cladribine enhances apoptotic cell death in lung carcinoma cells over-expressing DNase γ

Biol Pharm Bull. 2011;34(7):1001-4. doi: 10.1248/bpb.34.1001.

Abstract

Worldwide, lung cancer is the most common form of cancer and often has a poor prognosis. Establishment of effective therapies for lung cancer is a major concern in clinical cancer research. We compared the cytotoxic effects of chemotherapeutic agents including cisplatin, 5-fluorouracil, vinorelbine and cladribine, on a human lung cancer cell line, A549, and its derivative transfected with the DNase γ gene. We observed selective cytotoxicity of cladribine on the DNase γ-expressing sub-cell line of A549. Cladribine induces selective apoptosis in DNase γ-expressing A549 cells, which depends on activation of caspases. These results suggest that a combination therapy that includes cladribine along with the introduction of DNase γ has potential as a new therapeutic strategy for lung cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / enzymology
  • Adenocarcinoma / pathology*
  • Apoptosis / drug effects*
  • Cell Line, Tumor
  • Cladribine / pharmacology*
  • Endodeoxyribonucleases / metabolism*
  • Flow Cytometry
  • Humans
  • Lung Neoplasms / enzymology
  • Lung Neoplasms / pathology*

Substances

  • Cladribine
  • Endodeoxyribonucleases
  • deoxyribonuclease gamma